Sarissa Capital Management LP insider trades
Sarissa Capital Management LP has filed 16 Form 4s with the SEC that we hold, for Ironwood Pharmaceuticals INC (IRWD) (Director, 10% owner) and Innoviva, Inc. (INVA) (10% owner). Across all of them we count 6 purchases worth $2.9M and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 62,000 shares of Innoviva, Inc. worth $814.1K, dated 2023-06-15. The first filing on our record is dated 2021-12-17 and the latest 2025-06-17.
Ironwood Pharmaceuticals INC (IRWD)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Innoviva, Inc. (INVA)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-05-17 | P, purchase reported on Form 4 | 50,000 | $653.5K | 2023-05-19 |
| 2023-05-17 | P, purchase reported on Form 4 | 50,000 | $653.5K | 2023-05-19 |
| 2023-05-18 | P, purchase reported on Form 4 | 10,000 | $130.5K | 2023-05-19 |
| 2023-05-18 | P, purchase reported on Form 4 | 10,000 | $130.5K | 2023-05-19 |
| 2023-05-19 | P, purchase reported on Form 4 | 36,000 | $485.3K | 2023-05-19 |
| 2023-06-15 | P, purchase reported on Form 4 | 62,000 | $814.1K | 2023-06-20 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1577524) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms